BETHANECHOL CHLORIDE, Doses - BETAMETHASONE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE SODIUM PHOSPHATE

« »

BETHANECHOL CHLORIDE

↪ Doses - BETHANECHOL CHLORIDE Chemistry - A synthetic cholinergic ester, bethanechol occurs as a slightly hygroscopic, white orcolorless crystalline powder with a slight, amine-like or "fishy" odor. It exhibits polymorphism, with one form melting at 211° and the other form at... ↪ Read more

Doses - BETAMETHASONE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE SODIUM PHOSPHATE

↪ Description - BETAMETHASONE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE SODIUM PHOSPHATE Dogs: For the control of pruritis: a) Betasone® aqueous suspension: 0.25 - 0.5 ml per 20 pounds body weight IM. Dosedependent on severity of condition. May repeat when necessary. Relief averages... ↪ Read more

BETAMETHASONE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE SODIUM PHOSPHATE

↪ Doses - BETAMETHASONE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE SODIUM PHOSPHATE Note: For more information refer to the monograph: Glucocorticoids, General information . Chemistry - A synthetic glucocorticoid, betamethasone is available as the base and as the dipropionate, acetate and... ↪ Read more

Doses - BENAZEPRIL HCL

↪ Description - BENAZEPRIL HCL Dogs: For adjunctive treatment of heart failure: a) 0.25 - 0.5 mg/kg PO once daily (Miller and Tilley 1995) b) 0.25 - 0.5 mg/kg PO once to twice daily (Ware 1997) For adjunctive treatment of renal failure (progressive renal disease) or hypertension: a) 0.25... ↪ Read more

BENAZEPRIL HCL

↪ Doses - BENAZEPRIL HCL Chemistry - Benazepril HCl, an angiotensin converting enzyme inhibitor, occurs as white to off-white crystalline powder. It is soluble in water and ethanol. Benazepril does not contain a sulfhydryl group in its structure.Storage, Stability, Compatibility Benazepril... ↪ Read more

Doses - AZATHIOPRINE, AZATHIOPRINE SODIUM

↪ Description - AZATHIOPRINE, AZATHIOPRINE SODIUM Dogs: As an immunosuppressive: a) For adjunctive therapy for immune-mediated hemolytic anemia (probably should bereserved for dogs w/fulminant intravascular hemolysis, autoagglutination or those thatrequire repeated transfusion or have... ↪ Read more

AZATHIOPRINE, AZATHIOPRINE SODIUM

↪ Doses - AZATHIOPRINE, AZATHIOPRINE SODIUM Chemistry - Related structurally to adenine, guanine and hypoxanthine, azathioprine is a purineantagonist antimetabolite that is used primarily for its immunosuppressive properties. Azathioprineoccurs as an odorless, pale yellow powder that is... ↪ Read more

Doses - AZAPERONE

↪ Description - AZAPERONE Swine: a) For approved indication of mixing feeder or weanling pigs: 2.2 mg/kg deeply IM (seeclient information below) (Package Insert; Stresnil® ¯ P/M; Mallinckrodt) b) Preanesthetic:2 - 4 mg/kg IM; Immobilizing agent: 5.3 - 8 mg/kg IM (Swindle 1985) c)... ↪ Read more

AZAPERONE

↪ Doses - AZAPERONE Chemistry - A butyrephone neuroleptic, azaperone occurs as a white to yellowish-white macro-crystalline powder with a melting point between 90 - 95°C. It is practically insoluble in water and 1gram is soluble in 29 ml of alcohol.Storage, Stability, Compatibility... ↪ Read more

Doses - AUROTHIOGLUCOSE

↪ Description - AUROTHIOGLUCOSE Dogs: For canine pemphigus foliaceus/vulgaris: a) For those cases where corticosteroids and/or azathioprine are ineffective or causingunacceptable adverse effects: Discontinue azathioprine for one month and then give 1mg/5kg of body weight IM weekly for 10... ↪ Read more

AUROTHIOGLUCOSE

↪ Doses - AUROTHIOGLUCOSE Chemistry - A water soluble gold salt, aurothioglucose contains approximately 50% gold. It ispractically insoluble in alcohol and insoluble in vegetable oils. The commercial product is a 5% (50mg/ml) suspension in sesame oil, 2% aluminum monostearate, and... ↪ Read more

Doses - AURANOFIN

↪ Description - AURANOFIN Dogs: For treatment of gold-responsive dermatoses: a) 0.1 - 0.2 mg/kg PO daily (note: preliminary dosage) (Rosenkrantz 1989) For immune-mediated arthropathies and dermatopathies: a) 0.05 - 0.2 mg/kg (up to 9 mg/day total dose) PO q12h (Vaden and Cohn... ↪ Read more